Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000086

President & CEO gave up 2,205 shares (to pay taxes)

  • President & CEO acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hirsch Andrew · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-30 Exercise or conversion : show line 1 in the form +7,500 116,106 D
2023-08-30 Shares withheld for taxes : show line 2 in the form −2,205 $2.93 $6,461 113,901 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-30 Exercise or conversion : show line 3 in the form Performance Restricted Stock Units −7,500 55,000 D
Loading xslF345X05/wk-form4_1693512793.xml…